GPR65, a novel regulator of helper T‐cell polarization in inflammatory bowel disease

GPR65, a novel regulator of helper T‐cell polarization in inflammatory bowel disease

Bibliographic Details
Main Authors:	Jessica D. Hathaway‐Schrader, Chad M. Novince
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.857

Similar Items

Effector T Helper Cell Subsets in Inflammatory Bowel Diseases
by: Tanbeena Imam, et al.
Published: (2018-06-01)

Intestinal epithelial pH-sensing receptor GPR65 maintains mucosal homeostasis via regulating antimicrobial defense and restrains gut inflammation in inflammatory bowel disease
by: Gengfeng Li, et al.
Published: (2023-12-01)

Helper-Like Type-1 Innate Lymphoid Cells in Inflammatory Bowel Disease
by: Diana Coman, et al.
Published: (2022-06-01)

Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease
by: Shin-Huei Fu, et al.
Published: (2020-05-01)

Macrophage polarization in inflammatory bowel disease
by: Kun Zhang, et al.
Published: (2023-12-01)

GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis
by: Leila Gobejishvili
Published: (2024-01-01)

Association of SIRT-1, T helper 17-associated gene and Antimicrobial Peptides gene in Inflammatory Bowel Disease Patients
by: Magdy Amin El Serafy, et al.
Published: (2017-09-01)

Exploring the role of GPR65 in driving the pathology of ankylosing spondylitis
by: Barrett, J
Published: (2022)

GPR120 is an important inflammatory regulator in the development of osteoarthritis
by: Yuanfeng Chen, et al.
Published: (2018-08-01)

OGR1 (GPR68) and TDAG8 (GPR65) Have Antagonistic Effects in Models of Colonic Inflammation
by: Leonie Perren, et al.
Published: (2023-10-01)

GPR65 as a potential immune checkpoint regulates the immune microenvironment according to pan-cancer analysis
by: Liangliang Wang, et al.
Published: (2023-02-01)

C3a-C3aR signaling is a novel modulator of skeletal homeostasis
by: Megan B. Kuhn, et al.
Published: (2023-06-01)

Carbon dioxide inhibits UVB-induced inflammatory response by activating the proton-sensing receptor, GPR65, in human keratinocytes
by: Keimon Sayama, et al.
Published: (2021-01-01)

Exosome-Induced Regulation in Inflammatory Bowel Disease
by: Huiting Zhang, et al.
Published: (2019-06-01)

CCR9 Expressing T Helper and T Follicular Helper Cells Exhibit Site-Specific Identities During Inflammatory Disease
by: Ilaria Cosorich, et al.
Published: (2019-01-01)

Novel and Emerging Therapies for Inflammatory Bowel Disease
by: Badr Al-Bawardy, et al.
Published: (2021-04-01)

Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome
by: Porter Chad K, et al.
Published: (2012-05-01)

pH and proton sensor GPR65 determine susceptibility to atopic dermatitis
by: Xie, L, et al.
Published: (2021)

Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease
by: Qiuyun Xu, et al.
Published: (2021-03-01)

New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease
by: Jing Xu, et al.
Published: (2022-01-01)

NF-KB P65-subunit activity and T-helpers 1 / T-helpers 2 ratio in pregnant women with placental disorders and premature labor
by: I.B. Ventskivska, et al.
Published: (2023-03-01)

GPR37 and Related Receptors: Disease Regulation
by: Daniela Marazziti
Published: (2023-04-01)

Recent Strides in Novel Treatments for Inflammatory Bowel Disease
by: CHEN Xiaofen, CHEN Yuhan, MA Juan
Published: (2023-09-01)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
by: Federica Furfaro, et al.
Published: (2022-07-01)

Editorial: Novel Therapeutic Approaches in Inflammatory Bowel Diseases
by: Giovanni Pallio
Published: (2023-09-01)

Immunotherapy in inflammatory bowel disease: Novel and emerging treatments
by: Ignacio Catalan-Serra, et al.
Published: (2018-11-01)

Differentiation of T Helper 17 Cells May Mediate the Abnormal Humoral Immunity in IgA Nephropathy and Inflammatory Bowel Disease Based on Shared Genetic Effects
by: Jianbo Qing, et al.
Published: (2022-06-01)

Commensal Microbiota Effects on Craniofacial Skeletal Growth and Morphology
by: Joy E. Gerasco, et al.
Published: (2023-08-01)

Inflammatory bowel disease
by: Swiss Medical Weekly
Published: (2009-09-01)

INFLAMMATORY BOWEL DISEASE
by: I Gusti Ayu Mahaprani Danastri, et al.
Published: (2013-02-01)

Early development of a novel scale to measure adaptation in people diagnosed with inflammatory bowel disease - the A-inflammatory bowel disease
by: Lawrence Matini, et al.
Published: (2022-07-01)

The regulation of T helper cell polarization by the diterpenoid fraction of Rhododendron molle based on the JAK/STAT signaling pathway
by: JiaXu Qin, et al.
Published: (2022-10-01)

Interleukin-24 regulates mucosal remodeling in inflammatory bowel diseases
by: Anna Ónody, et al.
Published: (2021-06-01)

Angiocrine Regulation of Epithelial Barrier Integrity in Inflammatory Bowel Disease
by: Michael Stürzl, et al.
Published: (2021-08-01)

Adrenomedullin: A Novel Therapeutic for the Treatment of Inflammatory Bowel Disease
by: Shinya Ashizuka, et al.
Published: (2021-08-01)

Novel technologies to characterize and engineer the microbiome in inflammatory bowel disease
by: Alba Boix-Amorós, et al.
Published: (2022-12-01)

Molecular Mechanisms Regulating T Helper 1 versus T Follicular Helper Cell Differentiation in Humans
by: Nathalie Schmitt, et al.
Published: (2016-07-01)

GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response
by: Jianli Wang, et al.
Published: (2022-01-01)

Immunoepigenetic Regulation of Inflammatory Bowel Disease: Current Insights into Novel Epigenetic Modulations of the Systemic Immune Response
by: Guillermo Bastida, et al.
Published: (2023-02-01)

Hybrid T-helper cells: stabilizing the moderate center in a polarized system.
by: Sui Huang
Published: (2013-01-01)